In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Selfcare raises $9.3mm in IPO of 1.3mm shares at $8.50 a share

Executive Summary

Selfcare (self-test diagnostics in women's health, diabetes and infectious diseases) raised net proceeds of $9.3mm in its IPO of 1.3mm shares of common stock at $8.50 per share. The company originally offered 2.8mm shares, hoping to net $30mm.
Deal Industry
  • In Vitro Diagnostics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies